PharmaPlus offers services to biopharmaceutical companies to complement and enhance their business development activities throughout the deal-making process from partner identification to deal closure.

With our distinctive proprietary databases we help you find early stage licensing opportunties and valuate potential licensing deals.

Unpublished Pharma Patent Applications database

Find early stage inventions

PharmaPlus offers the Unpublished Pharma Patent Applications database. This online database especially responds to the demand for early stage inventions of investors and pharmaceutical and biotechnology companies. We provide industry …

Read more

Partnering Strategy

Define your partnering strategy

The right partnering strategy for a product or technology is essential for finding the most suitable partners. PharmaPlus is highly experienced in consulting on partnering strategies for third parties. We…

Read more

Non-confidential Teasers

Striking non-confidential teasers

How to gain attention from your potential partners? The initial non-confidential presentation of your product or technology is crucial. PharmaPlus is highly experienced in writing striking non-confidential teasers. Effective teasers …

Read more

Partnering Searches

Identify your potential partners

Are you looking for potential in-licensing and out-licensing partners? PharmaPlus performs partnering searches for third party life science products and technologies. We devotedly offer you a fully comprehensive solution to …

Read more

Licensing negotiations

Select package or single services

As a remarkable negotiator and experienced dealmaker PharmaPlus supports small and medium sized companies in their licensing deal negotiation process. Our expertise generates a premium in your deal value and …

Read more

Company licensing deals database extracts

Benchmark your deal value

How to obtain crucial knowledge for benchmarking your potential licensing deals? PharmaPlus owns offers premium company-company deal financials database, which solely focuses on therapeutics licensing deals from 1996 …

Read more